What is Research & Development (R&D)?

2 June 2026

When most people hear the term “Research & Development” (“R&D”), they think of scientists in laboratories or large technology companies building futuristic products. In reality, R&D is much broader than that, and many New Zealand businesses are undertaking R&D activities without even realising it.


At its core, R&D is about solving uncertainty through experimentation.


That concept of uncertainty is critical. The fact that something is new to your business, or even new to New Zealand, does not automatically make it R&D. Instead, the question is whether there is scientific or technological uncertainty that a competent professional in the field could not readily resolve using existing publicly available knowledge. 

If the answer is already known, or the solution can simply be implemented using existing techniques, it is unlikely to qualify as R&D.


However, if your business is trying to create something new, improve an existing product or process, or overcome technical challenges where the outcome is not already known, there is a good chance you may be undertaking R&D.


What does R&D actually involve?

R&D generally involves activities where a business is attempting to create new knowledge, or new or improved products, processes, or services, by systematically working through technical or scientific uncertainty. This means the answer is not already known or easily obtainable.


Examples can include:

  • developing and testing prototypes;
  • creating moulds or tooling to test whether a new concept can function commercially;
  • designing entirely new materials or products where the outcome is uncertain; 
  • scaling laboratory concepts; or 
  • pursuing ambitious or unconventional ideas that have not previously been achieved and where it is unclear whether they are technically possible. 


Importantly, R&D is not limited to “successful” projects. In many cases, failed experiments and unsuccessful prototypes are strong indicators that genuine uncertainty existed.


The importance of uncertainty

The key feature of eligible R&D is uncertainty.

For example:

  • creating software using standard coding practices is generally not R&D; 
  • configuring existing systems together is generally not R&D; and 
  • applying known techniques to achieve a predictable outcome is generally not R&D. 

However, where a business is attempting to solve a problem where:

  • the solution is not publicly known; 
  • existing technology cannot readily achieve the outcome; or 
  • experimentation is required to determine whether something is even possible, 

then the activity may qualify as R&D.


What is NOT eligible for R&D tax incentives?

Not every innovative activity qualifies as R&D for tax purposes. The focus is not on whether a business is commercially innovative, but whether genuine scientific or technological uncertainty exists.


Activities that are generally not considered eligible R&D include:

  • routine testing or quality control; 
  • cosmetic or minor product changes; 
  • ordinary troubleshooting; 
  • market research; 
  • standard commercial production activities; or 
  • work where the solution is already publicly known and can simply be implemented. 


In addition, a business may not qualify for the RDTI where it is performing R&D on behalf of someone else and does not own the resulting intellectual property (“IP”) or the results of the R&D.


There are also specific limitations where products generated during the R&D process are sold or commercialised. Under the “feedstock” rules, the amount of eligible R&D expenditure may be reduced where the costs are effectively recouped through the sale of products or outputs generated during the R&D activities.


Common examples of R&D in New Zealand businesses

Many industries undertake R&D, including sectors that would not traditionally view themselves as “technology companies”.


Examples where we have helped our clients claim R&D tax incentives include:

  • software companies developing AI-driven platforms or automation tools; 
  • manufacturers creating new biodegradable or sustainable materials; 
  • agricultural businesses trialling new farming technologies; 
  • engineering firms designing new systems or machinery;
  • food producers developing new formulations or preservation methods; 
  • construction businesses solving structural or materials challenges; and 
  • medical or biotech businesses developing new treatments, devices, or testing methodologies. 


New Zealand’s tax credits

New Zealand offers two key tax incentive regimes designed to encourage businesses to invest in innovation and R&D activities. Together, these regimes are intended to support businesses undertaking genuine scientific or technological development.


The Research & Development Tax Incentive (“RDTI”) provides a 15% tax credit for eligible R&D expenditure. 


The rules are highly technical and not all expenditure qualifies.  Notably, you generally need to have a minimum $50,000 eligible expenditure per year (which can include wages for time spent on eligible R&D projects).


In addition, loss-making companies may qualify for the Research & Development Tax Loss Cash-Out (“RDTLC”) regime, which can provide a cash refund of up to 28% of eligible R&D tax losses. 


Importantly, businesses can potentially “double dip” by:

  • claiming the 15% RDTI tax credit; and 
  • also accessing the RDTLC cash-out regime. 

However, there are detailed eligibility criteria and clawback rules that can apply in future years.


Final thoughts

R&D is not limited to large multinational companies or laboratories. Many ordinary New Zealand businesses undertake genuine R&D every day as they solve technical problems, improve products, and develop new technologies.


The challenge is often not whether R&D exists, but identifying it properly, documenting it correctly, and ensuring the associated tax treatment is managed appropriately.


If your business is investing significant time and money into innovation, it may be worthwhile reviewing whether some of those activities qualify as R&D for tax purposes.


If your business is investing in innovation, product development, software, engineering, or technical problem-solving, it may be worthwhile reviewing whether some of those activities qualify for New Zealand’s R&D tax incentives. Contact NZ Tax Desk to discuss your situation and assess whether your activities may be eligible.


We strive to add value to our clients. We are not just a computer algorithm based overseas, we are local experts that work closely with our clients throughout their start-up journeys.


Want to talk about your ideas? Your journey? Get in touch to arrange your complimentary introduction session now.


Disclaimer
This article is intended for general information purposes only and does not constitute tax, legal or financial advice. The application of New Zealand’s R&D tax incentive rules is highly fact specific. Professional advice should be obtained before taking any action or relying on the information contained in this article.

24 April 2026
If your business is undertaking research and development activities and has a 31 March 2026 balance date, then 30 June 2026 is the final deadline to submit your General Approval (GA) application if you want to claim the R&D Tax Incentive (RDTI) for FY26. This deadline is fast approaching, and it is critical. Without a GA in place, no RDTI claim can be made for the year. Importantly, this deadline is not just for new applications. It also applies where existing approvals need to be updated or expanded to reflect changes in your R&D programme. What Is the R&D Tax Incentive The RDTI is a government initiative that offers a 15% tax credit on eligible R&D expenditure. Its purpose is to support innovation by helping New Zealand businesses offset the cost of developing new or improved products, processes, or technologies. The regime applies to a wide range of industries, including software development, engineering, manufacturing, agritech, life sciences, and more – provided the activities meet the legislative definition of eligible R&D (i.e. they seek to resolve scientific or technological uncertainty through a systematic process). Key features include: 15% tax credit on eligible R&D expenditure Refundable credit for businesses in loss (subject to caps and criteria) Applies to R&D conducted in New Zealand Why You Need a General Approval To claim the RDTI, you must have a General Approval (GA) in place. This application outlines your core and supporting R&D activities and is reviewed and approved by Inland Revenue in advance of making your claim. The GA application requires you to clearly set out: The technical uncertainty being addressed Why the solution was not readily deducible by a competent professional The experimental process undertaken to resolve that uncertainty Having this in place before or during the income year gives your business certainty. You can proceed with your investment in innovation knowing the activities will qualify for the tax credit. If you have not yet submitted a GA application for the 2026 income year, you still have time, but the 30 June 2026 deadline is final for businesses with a 31 March balance date. If approved, the General Approval can apply for up to three years, allowing you to streamline future claims (but only to the extent your activities remain consistent with what was approved). General Approval application deadline for 31 March 2026 year-end: 30 June 2026 Note: If you have a non-standard balance date, your GA deadline may differ. Please contact us to confirm your specific due date. Where Experienced Claimants Still Get Caught Out Even for businesses with prior RDTI experience, we see a number of recurring issues: Scope drift from prior approvals: Projects evolve, but approvals often are not revisited. What was approved in an earlier year may not cover the current iteration of the work. Incomplete coverage of activities: Not all qualifying activities are captured within the GA, resulting in parts of the R&D programme falling outside the approved scope. Blurring of R&D and commercial activity: As projects move toward commercialisation, it becomes critical to clearly isolate the R&D. Framing the uncertainty incorrectly: Even where genuine R&D is occurring, applications can default to describing product outcomes or business challenges rather than technical uncertainty that is not readily deducible. Government grants: This area is currently a minefield with Inland Revenue. The interaction between grants and the RDTI can materially impact eligibility and claim values, and should be addressed upfront. Overseas activities not treated correctly: Activities performed offshore are often not recorded or assessed correctly against the RDTI rules, creating risk around eligibility and supportability of the claim. We work in this space every day. Whether it is identifying gaps in existing approvals, refining uncertainty narratives, dealing with grant interactions, or ensuring offshore activity is treated correctly, we help clients navigate these issues before they become problems. Changes to Existing Approvals: Do Not Assume You Are Covered A common misconception is that once a multi-year GA is in place, nothing further is required. In practice, many businesses need to update or supplement their approval each year. If your R&D activities in FY26 have: shifted in scope or direction, moved from feasibility into scale-up or deployment, incorporated new technologies or methodologies, or introduced new areas of uncertainty, then your existing GA may no longer fully cover the work being undertaken. In those cases, an updated or additional GA submission is required, and must also be filed by 30 June 2026. We recommend reviewing your existing General Approval before 30 June to confirm it still reflects your FY26 R&D activities, and whether any updates or a new application is required. We can assist with that review and ensure any required changes are identified and filed on time. How We Can Help We are a specialist R&D tax team with deep experience in New Zealand’s RDTI regime. We work with clients across software, engineering, biotech, and advanced manufacturing, and regularly support claims involving complex technical and eligibility issues. Our clients choose us for our: Technical depth and understanding of IRD’s eligibility criteria Ethical, fixed-fee pricing model – no % of your claim Flexible, low-touch process, so you can stay focused on growing your business Whether you need end-to-end support or just help with the General Approval, we can tailor our involvement to suit your needs. We will handle the complexity, engage with your team as required, and ensure your application is accurate, compliant, and optimised for success. If you think your business may qualify for the RDTI but have not yet submitted your General Approval, contact us today. We will help you assess eligibility, prepare your application, and unlock the full benefit of the incentive. Disclaimer: The information provided in this article is general in nature and does not constitute personalised tax advice. You should consult with a qualified tax adviser familiar with both US and NZ tax systems before making any decisions based on this content.
Hand circles the number 30 on a calendar with a red marker.
by Angela Hodges 6 June 2025
The Deadline is Approaching for FY25 General Approval Applications
A man is writing on a piece of paper while using a calculator.
by Angela Hodges 14 April 2025
If your business is carrying out research and development (R&D) work, you may be eligible to receive a cash payment from Inland Revenue— however there is limited time to act if you want to claim this for FY24.
A person is holding a plant growing out of a stack of coins.
by Angela Hodges 10 November 2021
A successful start-up company will typically have a five-stage journey: